Assessment of retinal morphology with spectral and time domain OCT in the phase III trials of enzymatic vitreolysis

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 11, 2012, Pages 7395-7401

  Folgar, Francisco A ^a   Toth, Cynthia A ^a   DeCroos, Francis Char ^a,b   Girach, Aniz ^c   Pakola, Steve ^c   Jaffe, Glenn J ^a  

^a DUKE UNIVERSITY EYE CENTER   (United States)

^b WILLS EYE HOSPITAL   (United States)

^c ThromboGenics NV   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

OCRIPLASMIN; PLACEBO; PEPTIDE FRAGMENT; PLASMIN;

ADHESION; ARTICLE; DRUG EFFICACY; EPIRETINAL MEMBRANE; FOLLOW UP; HUMAN; MACULAR THICKNESS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RETINA FOVEA; RETINA MACULA HOLE; RETINOSCHISIS; SINGLE DRUG DOSE; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBRETINAL FLUID; TIME DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TRACTION THERAPY; VITREORETINOPATHY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; INTRAVITREAL DRUG ADMINISTRATION; METHODOLOGY; PATHOLOGY; RETINA; RETINA TEAR; TREATMENT OUTCOME;

DOUBLE-BLIND METHOD; FIBRINOLYSIN; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETINA; RETINAL PERFORATIONS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84872029838     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10379     Document Type: Article

References (27)

1. Gallemore RP, Jumper JM, McCuen BW II, Jaffe GJ, Postel EA, Toth CA. Diagnosis of vitreoretinal adhesions in macular disease with optical coherence tomography. Retina. 2000;20:115-120.
2. McDonald HR, Johnson RN, Schatz H. Surgical results in the vitreomacular traction syndrome. Ophthalmology. 1994;101: 1397-1402.
3. Kakehashi A, Schepens CL, Trempe CL. Vitreomacular observations. II. Data on the pathogenesis of idiopathic macular breaks. Graefes Arch Clin Exp Ophthalmol. 1996; 234:425-433.
4. Smiddy WE, Michels RG, Green WR. Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders. A review. Retina. 1990;10:288-296.
5. Gaudric A, Haouchine B, Massin P, Paques M, Blain P, Erginay A. Macular hole formation: new data provided by optical coherence tomography. Arch Ophthalmol. 1999;117:744-751.
6. Kaiser PK, Riemann CD, Sears JE, Lewis H. Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol. 2001;131:44-49.
7. Massin P, Duguid G, Erginay A, Haouchine B, Gaudric A. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol. 2003; 135:169-177.
8. Koizumi H, Spaide RF, Fisher YL, Freund KB, Klancnik JM Jr, Yannuzzi LA. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;145: 509-517.
9. Takano M, Kishi S. Foveal retinoschisis and retinal detachment in severely myopic eyes with posterior staphyloma. Am J Ophthalmol. 1999;128:472-476.
10. Stalmans P, Benz MS, Gandorfer A, et al. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med. 2012;367:606-615.
11. Chang LK, Fine HF, Spaide RF, Koizumi H, Grossniklaus HE. Ultrastructural correlation of spectral-domain optical coherence tomographic findings in vitreomacular traction syndrome. Am J Ophthalmol. 2008;146:121-127.
12. Stopa M, Bower BA, Davies E, Izatt JA, Toth CA. Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies. Retina. 2008; 28:298-308.
13. Han IC, Jaffe GJ. Comparison of spectral-and time-domain optical coherence tomography for retinal thickness measurements in healthy and diseased eyes. Am J Ophthalmol. 2009; 147:847-858.
14. Sayanagi K, Sharma S, Yamamoto T, Kaiser PK. Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab. Ophthalmology. 2009;116:947-955.
15. Eriksson U, Alm A, Larsson E. Is quantitative spectral-domain superior to time-domain optical coherence tomography (OCT) in eyes with age-related macular degeneration? Acta Ophthalmol. In press.
16. Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT. Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci. 2008;49:4290-4296.
17. Gupta V, Gupta P, Singh R, Dogra MR, Gupta A. Spectraldomain Cirrus high-definition optical coherence tomography is better than time-domain Stratus optical coherence tomography for evaluation of macular pathologic features in uveitis. Am J Ophthalmol. 2008;145:1018-1022.
18. Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci. 2009;50:3432-3437.
19. Han IC, Jaffe GJ. Evaluation of artifacts associated with macular spectral-domain optical coherence tomography. Ophthalmology. 2010;117:1177-1189.
20. Giani A, Cigada M, Choudhry N, et al. Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. Am J Ophthalmol. 2010;150:815-824.
21. Falkner-Radler CI, Glittenberg C, Hagen S, Benesch T, Binder S. Spectral-domain optical coherence tomography for monitoring epiretinal membrane surgery. Ophthalmology. 2010;117:798-805.
22. Zhang N, Hoffmeyer GC, Young ES, et al. Optical coherence tomography reader agreement in neovascular age-related macular degeneration. Am J Ophthalmol. 2007;144:37-44.
23. Patel PJ, Chen FK, Ikeji F, et al. Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49: 1084-1088.
24. Krebs I, Hagen S, Brannath W, et al. Repeatability and reproducibility of retinal thickness measurements by optical coherence tomography in age-related macular degeneration. Ophthalmology. 2010;117:1577-1584.
25. Pierro L, Giatsidis SM, Mantovani E, Gagliardi M. Macular thickness interoperator and intraoperator reproducibility in healthy eyes using 7 optical coherence tomography instruments. Am J Ophthalmol. 2010;150:199-204.
26. DeCroos FC, Toth CA, Folgar FA, et al. Characterization of vitreoretinal interface disorders using OCT in the interventional phase III trials of ocriplasmin. Invest Ophthalmol Vis Sci. 2012;53:6504-6511.
27. Aaker GD, Gracia L, Myung JS, et al. Three-dimensional reconstruction and analysis of vitreomacular traction: quantification of cyst volume and vitreoretinal interface area. Arch Ophthalmol. 2011;129:809-811.